Successful phase 2 be proof of concept pancreatic trial on a shoestring budget. Negotiated and OUTSTANDING co-development deal with large pharma without any leaks of information. Two phase 3 GLOBAL late stage trials with SPA and orphan. Numerous other indications in the pipe. 110 million in the bank with NO DEBT. Significant up coming milestones to report. I can go on and on and on. I just touched on the few highlights.
It could go either way Framus . A PR, or maybe AF and the peanut gallery might actually create a little " BUZZ ". Actually, that would scare me. Especially if the short interest went up to 14 million shares ! :O